CC-BY-NC-ND 4.0 · THORAC CARDIOV SURG Reports 2017; 06(01): e29-e31
DOI: 10.1055/s-0037-1606345
Case Report Cardiac
Georg Thieme Verlag KG Stuttgart · New York

Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation

Daniel Reichart1, Niklas Schofer2, Florian Deuschl2, Andreas Schaefer1, Stefan Blankenberg2, Hermann Reichenspurner1, Ulrich Schaefer2, Lenard Conradi1
  • 1Department of Cardiovascular Surgery, Universitätsklinikum Hamburg–Eppendorf, Universitäres Herzzentrum Hamburg GmbH, Hamburg, Germany
  • 2Department of General and Interventional Cardiology, Universitätsklinikum Hamburg–Eppendorf, Universitäres Herzzentrum Hamburg GmbH, Hamburg, Germany
Further Information

Publication History

31 March 2017

19 July 2017

Publication Date:
18 September 2017 (online)

Abstract

Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce.

Case Description Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position.

Conclusion This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.